The HFSA Heart Failure Seminars, launched in 2022, are 1 ½ hour virtual seminars in which HFSA brings together experts in the field to provide an update on a key topic. During the live virtual seminar, experts present information relevant to the entire HF care team with live Q&A taking place throughout the seminar. The seminar is then offered OnDemand in the HFSA Learning Center for attendees to access on their own schedule.
Heart Failure Seminars Currently Available
Live - Scheduled
HFSA Heart Failure Seminar: Focus on Devices
Thursday, June 22, 2023
5:00 PM - 6:30 PM ET | Virtual Livestream
OnDemand
Debates on Best Outcomes with Percutaneous vs Surgical Interventions
Price
- Member: $49.00
- Non-Member: $89.00
Credits
- 1.5 CME Credits
- 1.5 CNE Credits
Full Details
This seminar will feature heart failure experts discussing percutaneous and surgical interven-tions. Despite the advances in medical therapy, with growing benefit from the “4 pillars” of guide-line directed medical therapy (GDMT), subsets of patients derive signification improvement in out-comes utilizing advanced percutaneous and surgical interventions via improvement in coronary flow, valvular function, and pump function.
Price
- Member: $0.00
- Non-Member: $50.00
Credits
N/A
Full Details
This virtual seminar will feature a multidisciplinary panelist of heart failure experts discussing the challenges and opportunities with implementing the updated Guideline-Directed Medical Therapy (GDMT). Attendees will be presented with case study vignettes that will drive meaningful and engaging discussions. Conversations amongst the panelist include how to navigate cost and availability of medication, and how the new value statements may help to support and inform patient engagement.
Everything you want to know, and not afraid to ask: The evidence, the how, and the challenges.
Price
- Member: $35.00
- Non-Member: $50.00
Credits
- 1.5 CNE Credits
- 1.5 CPE Credits
- 1.5 CEU Credits
Full Details
The optimization of GDMT in the treatment of HF has been shown to reduce morbidity and mortality and improve patient outcomes. However, many HF patients do not receive GDMT and/or achieve the recommended target dose of their medications. Studies have shown that while most patients are managed by cardiologists or primary care practitioners, GDMT and target doses of medication can also be successfully achieved by expanding this role to other providers. Education on GDMT, optimizing medications, and these successful strategies are needed to expand patient outcomes. This program will provide practitioners with updated information on the universal definition of heart failure, guideline-directed medical therapies (GDMT), and strategies that optimize medical therapies (OMT) to improve patient outcomes.
Original Seminar Date: April 22,2022
Product Expiration Date: May 6, 2023
2023 HFSA Heart Failure Seminars Planned*:
- Focus on Interventions for Heart Disease: Percutaneous and Surgical Interventions for Ischemic and Structural Heart Disease in Heart Failure Patients. Which has Superior Outcomes? - February 2, 2023
- Focus on HF Devices - June 22, 2023
- Focus on Sleep in HF - September 14, 2023
- Focus on Hypertrophic Cardiomyopathy (HCM) - November 2023
- Focus on Iron Deficiency in HF - December 2023
*Subject to change